Brokers are a very efficient and cost effective distribution...

First 70 Last

Share
Profile

Follow
australiasydney

680 Posts.

297

15/11/21

22:50

Post #: 57597182
Share

Originally posted by Lillard0: ↑

Hard to ask about fees, penalties and rate if you don’t know the lender exists. Why do customers still go to big 4 banks for personal loans? It certainly isn’t the rate, it’s because they are well established brands that people know about. Unless you want all your originations to come from broker you need to spend money becoming a household name, or at least a name people are somewhat aware of. A customer who approaches Wisr for finance directly is more profitable than a customer who ends up there via broker channel because there is no need to pay up front commission or trail. This is the exact reason why the Wisr app downloads are important, because those users get exposed to Wisr and can then think to approach directly when the time/need comes. Of course to grow this awareness takes time and money and in the meanwhile broker is important to keep deals coming in the door and keep the lights on.

Wisr needs to continue to build brand awareness and advocacy while continuing to invest in the platform to make customer interactions simple and fast. To simply rely on being the cheapest is a very poor strategy because there will always be a cheaper alternative.

Expand

Brokers are a very efficient and cost effective distribution channel.

No salary and wages, no TV spend , no app development.

Pay an upfront fee to them on success only.

WZR Price at posting: 24.0¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 23 more messages in this thread...

First 70 Last

Add WZR (ASX) to my watchlist

(20min delay)
Last 2.9¢		Change 0.001(3.57%)		Mkt cap ! $40.03M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.8¢	$1.313K	46.13K

Buyers (Bids)

No.	Vol.	Price($)
2	60656	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	977305	5

View Market Depth

No.	Vol.	Price($)
2	60656	0.028
2	318924	0.027
1	30000	0.026
5	673413	0.025
1	600000	0.024

Price($)	Vol.	No.
0.029	977305	5
0.030	287036	3
0.031	426774	2
0.033	181828	2
0.034	267613	2

Last trade - 16.10pm 07/10/2024 (20 minute delay)

WZR (ASX) Chart

Brokers are a very efficient and cost effective distribution...

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Brokers are a very efficient and cost effective distribution...

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News